Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer.
Zafiropoulos
A
A
Crikas
N
N
Passam
A M
AM
Spandidos
D A
DA
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000235:genetics*; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D054390:Receptors, CCR2; D019713:Receptors, CCR5 / Q000235:genetics; D019707:Receptors, Chemokine / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics; D001749:Urinary Bladder Neoplasms / Q000235:genetics
C515334:CCR2 protein, human; C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D054390:Receptors, CCR2; D019713:Receptors, CCR5; D019707:Receptors, Chemokine